2results about How to "Expanded indications" patented technology

The application discloses a new application of SCH772984 in treating SPSB1 high-expression tumors. It is found for the first time that SCH772984 can be used as an SPSB1 inhibitor and has a therapeutic effect on SPSB1 high-expression diseases such as tumors and infectious diseases, and has a wide clinical application prospect.

The present application relates to the technical field of bioengineering, and particularly relates to a fermented liquid of Gomphrena yatschekii, a fermentation method and application thereof.The present application provides a fermentation method of Gomphrena yatschekii, comprising the following steps: (1) mixing Gomphrena yatschekii with mixed enzymes for enzymolysis, and sterilizing to obtain an enzymolysis liquid of Gomphrena yatschekii; (2) mixing the enzymolysis liquid of Gomphrena yatschekii with a compound microbial agent for fermentation, and filtering and sterilizing after fermentation to obtain a fermented liquid of Gomphrena yatschekii; the compound microbial agent is Lactobacillus plantarum LZU-J-TSL6 and Lactobacillus plantarum LZU-J-QA25.After fermentation by the method, the effective components in Gomphrena yatschekii are fully dissolved, the drug activity is improved and increased, the body can rapidly absorb the drug, inflammation and oxidative stress can be regulated, and gastric ulcer can be resisted.